We also evaluated the effects of CD79A+CD24-PANCK+-BCSCs subpopulation and CD8+FOXP3+ T cells on breast cancer patients survive status, finding that both CD79A+CD24-PANCK+-BCSCs cells-High and CD8+FOXP3+ cells-High (within 50 μm to CD79A+CD24-PANCK+-BCSCs subpopulation) had poorer survival probability (Fig. 9e, f), further indicating that these two groups of cells contribute to poor prognosis may due to the tumor immunosuppressive microenvironment they shaped. The gene discussed is CD79A; the disease is breast carcinoma.